Insuman Comb 30

Insulin human, the active ingredient in Insuman Comb 30, is a insulin presented as a premixed injectable formulation for subcutaneous use. It is used to lower blood glucose in patients with diabetes mellitus, both type 1 and type 2. GNH USA supplies Insuman Comb 30 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Insuman Comb 30 is an insulin preparation that acts on the glucose regulation pathway in diabetes mellitus. - Type 1 diabetes mellitus: provides basal and prandial glucose control in insulin‑deficient patients. - Type 2 diabetes mellitus: improves glycaemic control when oral agents are insufficient. - Gestational diabetes mellitus: offers safe insulin therapy to maintain maternal and fetal glucose levels.

Common Side Effects: - Hypoglycaemia: low blood sugar episodes, especially if meals are missed or dosing is excessive. - Injection site reactions: redness, swelling, or itching at the injection site. - Weight gain: increased caloric storage due to improved glucose utilization. - Edema: mild fluid retention, particularly in the lower extremities. - Lipodystrophy: localized changes in fat tissue with repeated injections.

Serious or Rare Side Effects: - Severe hypoglycaemia: neuroglycopenic symptoms requiring immediate assistance. - Allergic reactions: urticaria, angioedema, or anaphylaxis. - Insulin antibodies: may alter insulin effectiveness and cause resistance. - Hypokalemia: low potassium levels secondary to intracellular shift. - Acute pancreatitis: rare inflammatory response of the pancreas.

Insuman Comb 30 requires careful monitoring and patient education. - Dose adjustment: individualize based on blood glucose monitoring and dietary intake. - Hypoglycaemia risk: advise patients to recognize early signs and have rapid‑acting carbohydrate available. - Concomitant illnesses: infections or stress may increase insulin requirements. - Pregnancy and lactation: use only if benefits outweigh potential risks and under medical supervision. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake the vial.

Insuman Comb 30 may interact with several drug classes. Major Interactions (Avoid): - Beta‑blockers: can mask hypoglycaemia symptoms, requiring closer glucose monitoring. - Sulfonylureas or meglitinides: additive risk of severe hypoglycaemia. - Alcohol: potentiates insulin’s glucose‑lowering effect, increasing hypoglycaemia risk. Moderate Interactions (Monitor Closely): - Corticosteroids: may raise blood glucose, necessitating dose adjustments. - Thiazide diuretics: can impair glucose tolerance, requiring closer monitoring. - Thyroid hormones: alterations in metabolic rate may affect insulin needs.